Haploidentical transplantation combined with mesenchymal stem cells co-infusion improves survival in severe aplastic anemia: a single-center retrospective study
This study demonstrates that combining HID-HSCT with MSCs co-infusion is a safe and effective therapeutic strategy that significantly improves survival rates and quality of life in SAA patients.
Authors
- Ningning Zhu
- Dijiong Wu
- Liqiang Wu (ORCID: https://orcid.org/0000-0001-6547-2461)
- Baodong Ye (ORCID: https://orcid.org/0000-0001-5912-2633)
- Tonglin Hu
- Qinghong Yu (ORCID: https://orcid.org/0000-0002-7326-7609)
- Yuechao Zhao (ORCID: https://orcid.org/0000-0001-5334-6281)
- Huijin Hu
- Wenbin Liu (ORCID: https://orcid.org/0000-0002-6230-9623)
- Jingjing Liu (ORCID: https://orcid.org/0000-0001-9672-2144)
- Yu Zhang (ORCID: https://orcid.org/0000-0002-5430-6772)
- Zhengwei Tan
- Monique G. Lê (ORCID: https://orcid.org/0009-0005-8271-1280)
Institutions
- Zhejiang Chinese Medical University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-11-28
- DOI
- https://doi.org/10.3389/fmed.2025.1711958
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China